tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALT Stock Latest News

Altimmune announces publication of study of pemvidutide in MASLD
The FlyAltimmune announces publication of study of pemvidutide in MASLD
1d ago
ALT
Altimmune Announces Publication of Clinical Study of Pemvidutide in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Journal of Hepatology
PremiumPress Releases
Altimmune Announces Publication of Clinical Study of Pemvidutide in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Journal of Hepatology
1d ago
ALT
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
PremiumThe Fly
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
14d ago
ALT
PFE
Altimmune management to meet virtually with B. Riley
PremiumThe Fly
Altimmune management to meet virtually with B. Riley
18d ago
ALT
Altimmune to Participate at Leerink Partners Therapeutics Forum
PremiumPress Releases
Altimmune to Participate at Leerink Partners Therapeutics Forum
24d ago
ALT
Class Action Lawsuit against Altimmune, Inc. (NASDAQ:ALT)
PremiumMarket NewsClass Action Lawsuit against Altimmune, Inc. (NASDAQ:ALT)
28d ago
ALT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
29d ago
ALT
WVE
Altimmune jumps after NY Post highlights this week’s weight loss data
PremiumThe Fly
Altimmune jumps after NY Post highlights this week’s weight loss data
29d ago
ALT
Altimmune jumps 5% to $6.57 after New York Post highlights weight loss drug
PremiumThe Fly
Altimmune jumps 5% to $6.57 after New York Post highlights weight loss drug
29d ago
ALT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ALT
ABIO
Altimmune Appoints Andrew Shutterly as New CFO
PremiumCompany Announcements
Altimmune Appoints Andrew Shutterly as New CFO
1M ago
8K
ALT
Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt
PremiumPress Releases
Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt
1M ago
ALT
Altimmune announces passing of CFO Richard Eisenstadt
PremiumThe FlyAltimmune announces passing of CFO Richard Eisenstadt
1M ago
ALT
Altimmune body composition data ‘impressive,’ says B. Riley
PremiumThe Fly
Altimmune body composition data ‘impressive,’ says B. Riley
1M ago
ALT
Unusually active option classes on open June 24th
PremiumThe Fly
Unusually active option classes on open June 24th
1M ago
PG
ALT
Altimmune data show differentiated lipid benefits, says JMP Securities
PremiumThe Fly
Altimmune data show differentiated lipid benefits, says JMP Securities
1M ago
ALT
Altimmune presents data from Phase 2 MOMENTUM trial of pemvidutide
PremiumThe Fly
Altimmune presents data from Phase 2 MOMENTUM trial of pemvidutide
1M ago
ALT
Altimmune Presents Data from Phase 2 MOMENTUM Trial of Pemvidutide in Obesity during Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
PremiumPress Releases
Altimmune Presents Data from Phase 2 MOMENTUM Trial of Pemvidutide in Obesity during Oral Presentation at the American Diabetes Association’s 84th Scientific Sessions
1M ago
ALT
Short Report: Sirius XM bears pressing bets into stock rally
PremiumThe Fly
Short Report: Sirius XM bears pressing bets into stock rally
1M ago
ALT
KSS
Altimmune Presents Data on the Effect of Pemvidutide on Cardioinflammatory Lipids during Oral Presentation at American Diabetes Association’s 84th Annual Scientific Sessions
PremiumPress ReleasesAltimmune Presents Data on the Effect of Pemvidutide on Cardioinflammatory Lipids during Oral Presentation at American Diabetes Association’s 84th Annual Scientific Sessions
1M ago
ALT
Altimmune to Participate in the Piper Sandler 2nd Annual Virtual Obesity Investor Day to Discuss ADA Takeaways
PremiumPress Releases
Altimmune to Participate in the Piper Sandler 2nd Annual Virtual Obesity Investor Day to Discuss ADA Takeaways
1M ago
ALT
Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions
PremiumPress Releases
Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions
1M ago
ALT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >